Register Now for The Outlook on Active Nutrition
News|Articles|February 11, 2026

Nutritional Outlook

  • Nutritional Outlook Vol. 29, No. 1
  • Volume 29
  • Issue 1

Ashwagandha's advancement: The ingredient is seeing greater adoption by manufacturers due to its many potential benefits and consumer recognition

Listen
0:00 / 0:00

Key Takeaways

  • Mainstream MULO growth reached $176 million, driven by expanding consumer recognition and increased inclusion across diverse formulations such as stress, energy, and male health products.
  • Market maturation has hinged on standardization, acknowledging variability by plant part, extraction, and specifications, thereby improving predictability and strengthening consumer trust.
SHOW MORE

Ashwagandha is finding its way into more products as research grows on the ingredient's health benefits, and formulators push the boundaries of alternative dosage formats.

Ashwagandha continues to have a prominent presence in the nutraceutical space, growing 27% in the mainstream multioutlet channel (MULO) to reach $176 million, according to data from SPINS, based on the 52 weeks ending November 30, 2025. The ingredient has been performing well for years, booming in 2021, then leveling off in 2022, essentially becoming a mainstay of the industry. According to Scott Dicker, senior director of market insights for SPINS, we’re still seeing the lifecycle of ashwagandha play out.

“There's a lot of adaptation to [the] conventional [channel], so we're still seeing that life cycle play out. We like to talk about how fast the life cycle is now, but it still happens over some period of time,” he explains. “It is being used in more and more formulas as well. I've been seeing a lot of male health formulas now having ashwagandha in it, along with stress and energy. So, when you have an ingredient that’s being touted for such a wide range of health focuses, and more and more consumers are aware of it, I think the that brands always look to it as a nice one to put in their formulations and bring to market. So you're still seeing new brands adding it.”

According to Kartikeya Baldwa, CEO of Ixoreal Biomed, maker of KSM-66 ashwagandha, the modernization of this traditional ingredient has been instrumental in the adoption of ashwagandha products, and its wide acceptance. “Ashwagandha moved from folklore to evidence,” he explains. “Consumers were ready for solutions that support stress resilience, sleep quality, and daily balance, but what actually unlocked wide acceptance was the category getting more disciplined about quality, consistency, and research.”

There were three shifts in the market that contributed to ashwagandha’s growth and current profile, he explains. The first was standardization and strict specifications. “The market had to learn that ‘ashwagandha’ is not one uniform ingredient,” says Baldwa. “Differences in plant part, extraction process, and standardization approach can materially change what you are actually putting in a product. Once standardization improved, outcomes became more predictable. That is when consumer trust started to build.”

The second shift was a more mature understanding of quality. With the rise of ashwagandha, brands have been figuring out the best ways to position and market their ashwagandha products. At the same time, consumers have been learning what works and what doesn’t for them. There are a number of ways to approach formulation, but a few things must hold true. “What matters is repeatable composition, responsible dosing, and clinical validation that reflects how real people use the ingredient over time,” he explains.

Finally, Baldwa says that ashwagandha fits the evolving needs of consumers. “People are not just looking for energy or intensity anymore,” he explains. “They want to function better under pressure. They want calm, focus, better recovery, and quality sleep. Ashwagandha fits those needs well when it is produced responsibly and positioned with restraint.”

Ashwagandha Benefits

Consumers shop by health benefit, says Dicker. “For most things, people lead with benefit, but then they do turn the label around, or search for it, and see if there are ingredients that they’ve heard of, or want to try,” he explains. “The more popular and well known an ingredient gets, the more it will go to the top of the try-list for consumers.”

“The next phase of growth will come from more precise benefit positioning and better delivery formats,” adds Baldwa. “But the brands that win will be those that keep their claims responsible and grounded.”

Ashwagandha is well recognized, but that recognition is most effective when paired with a health benefit. It’s no secret that a desirable health benefit plus a recognized and trusted ingredient is part of a winning product formula, but as Baldwa notes, how that benefit is positioned goes a long way as well. Sleep, for example, is something that can be addressed acutely or more holistically. According to Baldwa, consumers are beginning to see the benefits of a more holistic approach.

“Consumers have moved past simply wanting to fall asleep,” he says. “They care about restorative sleep and how they feel the next day. This is a meaningful space for ashwagandha when it is used as part of a broader routine, not as a magic pill.”

This is similar for stress management and mental performance. Non-stimulating products that help with focus and stress-management that offer more than a temporary solution are highly desirable. “Ashwagandha can be relevant here because it supports resilience without promising a quick fix,” says Baldwa.

A major area of opportunity Baldwa points to is life stage wellness, such as women’s health and longevity more broadly. “The opportunity is large, but it demands careful communication and well-defined research outcomes,” he explains. “Stretch the claims and you lose credibility fast.”

Fast-growing categories like menopause support offer great opportunity, but the people buying these products want results. Without evidence-based formulation that creates effective products, consumers will quickly turn to something else.

Formulation Considerations

One of the major contributions to ashwagandha’s growth was the launch of the ingredient in a gummy format. This continues to be an important factor in ashwagandha’s continued growth and innovations, but form should not exceed function.

“On dosage form, the opportunity is about reducing friction in daily use,” says Baldwa. “Capsules are not going away, but growth is accelerating in gummies, stick packs, ready to mix powders, chewables, and beverage formats. The point is not novelty for its own sake. The point is compliance and consistency. A format is only an innovation if it preserves the actives, delivers a reliable dose, and fits into how people actually live.”

Traceable, standardized, validated ingredients are therefore crucial for not just creating an effective product that consumers will come back to, but also ensuring safety and credibility. “The way I see it, the category’s long term growth depends on trust,” says Baldwa. “Trust comes from transparency, consistent composition, ingredient specific research and a mature approach to quality that does not reduce performance to a single metric.”

Access full Ingredients to Watch coverage, with detailed sales data across the mainstream multioutlet and natural channels here.

Listen to The Nutritional Outlook Podcast for the full interview with Scott Dicker, senior director, market insights, at SPINS.